Company page

Kalaris Therapeutics, Inc.

Kalaris Therapeutics, Inc. (ticker: KLRS) is a public company operating in the American market with a market capitalization of approximately $103 million. The company focuses on developing innovative therapeutic solutions. Kalaris aims to address unmet medical needs through its research and development efforts.